SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Dicerna Pharmaceuticals Awarded Notice of Allowance by U.S. Patent and Trademark Office for Patent Claims Broadly Covering Dicer Substrate siRNA Molecules